You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華北製藥(600812.SH):購買愛諾公司51%股權等事宜已基本完成標的資產審計評估工作
格隆匯 06-12 20:10

格隆匯6月12日丨華北製藥(600812.SH)公佈,華北製藥股份有限公司(以下簡稱“公司”)擬通過發行股份及支付現金方式購買公司股東華北製藥集團有限責任公司所持有的華北製藥集團愛諾有限公司51%股權(截至本公告日,公司已持有愛諾公司49%股權)、華北製藥集團動物保健品有限責任公司100%股權及華北牌系列商標資產;同時,公司擬非公開發行股份募集配套資金。

自本次資產重組預案披露以來,公司及相關各方積極推進本次資產重組的各項工作。截至本公告披露日,本次資產重組涉及的相關工作具體進展情況如下:

1、審計機構已基本完成標的資產的審計工作,正在履行內部複核流程;

2、資產評估機構已基本完成標的資產的評估工作,正在履行國有資產監督管理部門或其授權機構的備案程序;

3、獨立財務顧問和專項法律顧問已基本完成對標的資產盡職調查工作,正在整理資料並對盡職調查情況進行復核,修訂和完善相關報告文件。

截至本公告披露日,公司已按照《上市公司重大資產重組管理辦法》等法律法規和規範性文件的有關規定,履行了相關決策程序,及時披露了相關信息,並向廣大投資者提示了本次重組事項的不確定性風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account